Actualites Pharmaceutiques最新文献

{"title":"Accompagner les patients face aux problématiques d’accès aux traitements à l’officine","authors":"Sandrine Nail-Billaud (Docteure en pharmacie, maîtresse de conférences)","doi":"10.1016/j.actpha.2026.02.009","DOIUrl":"10.1016/j.actpha.2026.02.009","url":null,"abstract":"<div><div>Face aux difficultés croissantes d’accès aux médicaments, le pharmacien d’officine joue un rôle central dans la continuité des soins. Grâce à différents outils, il identifie les alternatives, informe les patients et coordonne avec les prescripteurs. Au-delà de sa capacité à gérer une rupture, son écoute et sa pédagogie sont essentielles pour maintenir la confiance. L’officine devient ainsi un véritable pivot d’accès aux soins dans le but de garantir l’observance du patient, en s’adaptant à chaque cas particulier.</div></div><div><div>Faced with increasing difficulties in accessing medicines, community pharmacists play a central role in ensuring continuity of care. Using a range of tools, they identify alternatives, inform patients, and coordinate with prescribers. Beyond their ability to manage shortages, their listening skills and educational approach are essential for maintaining trust. The pharmacy thus becomes a true hub for access to care, with the aim of ensuring patient compliance by adapting to each individual case.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 35-39"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Les papillomavirus, infections et vaccination","authors":"Damien Malbos (Docteur en pharmacie)","doi":"10.1016/j.actpha.2026.02.012","DOIUrl":"10.1016/j.actpha.2026.02.012","url":null,"abstract":"<div><div>Les papillomavirus humains (HPV) sont à l’origine d’infections virales courantes. Environ 80  % des personnes sexuellement actives seront en contact au moins une fois dans leur vie avec ce type de virus. Bien que les infections à HPV soient majoritairement bénignes, certaines exposent à un haut risque oncogène. L’équipe officinale a un rôle clé à jouer dans leur prévention et leur prise en charge.</div></div><div><div>Human papillomaviruses (HPV) cause common viral infections. Approximately 80 % of sexually active individuals will come into contact with this type of virus at least once in their lifetime. Although HPV infections are mostly benign, some carry a high oncogenic risk. Pharmacy teams have a key role to play in their prevention and management.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 47-50"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extension des missions des pharmaciens : ne pas sortir du cadre légal","authors":"Mathieu Guerriaud (Professeur en droit pharmaceutique et de la santé, histoire de la pharmacie et de la santé)","doi":"10.1016/j.actpha.2026.02.001","DOIUrl":"10.1016/j.actpha.2026.02.001","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Page 1"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"santé publique","authors":"","doi":"10.1016/j.actpha.2026.03.018","DOIUrl":"10.1016/j.actpha.2026.03.018","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Page 6"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Renforcer le rôle du pharmacien dans la prise en charge des douleurs neuropathiques","authors":"Emma Heslot (Pharmacienne) ,&nbsp;Éric Barat (Pharmacien, praticien hospitalier universitaire)","doi":"10.1016/j.actpha.2026.02.005","DOIUrl":"10.1016/j.actpha.2026.02.005","url":null,"abstract":"<div><div>Les douleurs neuropathiques constituent une pathologie chronique complexe et souvent difficile à identifier. Le rôle du pharmacien d’officine dans leur prise en charge a été exploré à travers une revue des connaissances et une enquête. L’identification de ces douleurs repose principalement sur l’analyse de l’ordonnance et le dialogue avec le patient, avec un recours très limité aux outils standardisés. Malgré un intérêt clairement exprimé, des obstacles persistent, tels que l’absence de protocoles dédiés et de dispositifs permettant de formaliser les pratiques. Des pistes d’amélioration peuvent être proposées.</div></div><div>Les douleurs neuropathiques constituent une pathologie chronique complexe et souvent difficile à identifier. Le rôle du pharmacien d’officine dans leur prise en charge a été exploré à travers une revue des connaissances et une enquête. L’identification de ces douleurs repose principalement sur l’analyse de l’ordonnance et le dialogue avec le patient, avec un recours très limité aux outils standardisés. Malgré un intérêt clairement exprimé, des obstacles persistent, tels que l’absence de protocoles dédiés et de dispositifs permettant de formaliser les pratiques. Des pistes d’amélioration peuvent être proposées.</div><div><div>Neuropathic pain is a complex chronic condition that is often difficult to identify. The role of community pharmacists in managing this condition was explored through a review of the literature and a survey. The identification of this pain is based mainly on the analysis of prescriptions and dialogue with patients, with very limited use of standardized tools. Despite clearly expressed interest, obstacles remain, such as the lack of dedicated protocols and mechanisms for formalizing practices. Areas for improvement can be proposed.</div></div><div>Neuropathic pain is a complex chronic condition that is often difficult to identify. The role of community pharmacists in managing this condition was explored through a review of the literature and a survey. The identification of this pain is based mainly on the analysis of prescriptions and dialogue with patients, with very limited use of standardized tools. Despite clearly expressed interest, obstacles remain, such as the lack of dedicated protocols and mechanisms for formalizing practices. Areas for improvement can be proposed.</div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 19-23"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"profession","authors":"","doi":"10.1016/j.actpha.2026.03.017","DOIUrl":"10.1016/j.actpha.2026.03.017","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 4-5"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perte d’autonomie d’une personne âgée","authors":"Jean-Michel Mrozovski (Président d’honneur de la Coopération pour la valorisation de l’acte officinal (CVAO))","doi":"10.1016/j.actpha.2026.02.015","DOIUrl":"10.1016/j.actpha.2026.02.015","url":null,"abstract":"<div><div>De nombreuses personnes âgées se trouvent en situation de perte d’autonomie. Elles souffrent de problèmes associés au poids ou de manque de mobilité en lien avec une ou plusieurs pathologies chroniques. Cette situation peut être silencieuse.</div></div><div><div>Many elderly people find themselves losing their independence. They suffer from weight-related problems or lack of mobility linked to one or more chronic conditions. This situation can be silent.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 59-61"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Garantir l’accès aux médicaments, un défi entre tensions et innovations","authors":"Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2026.02.007","DOIUrl":"10.1016/j.actpha.2026.02.007","url":null,"abstract":"<div><div>En France, l’accès aux médicaments fait aujourd’hui face à de multiples défis. Les médicaments anciens, souvent essentiels, sont fragilisés par des prix décroissants, des tensions d’approvisionnement et une production délocalisée qui favorisent les ruptures quand l’arrivée des innovations thérapeutiques va de pair avec des contraintes réglementaires, des négociations de prix complexes et un coût élevé pour la collectivité. Garantir un accès équitable et pérenne aux médicaments nécessite d’articuler solidarité et innovation, en repensant la régulation, en sécurisant la production et en valorisant le rôle central des pharmaciens.</div></div><div><div>In France, access to medicines currently faces multiple challenges. Older medicines, which are often essential, are being undermined by falling prices, supply tensions, and offshore production, which can lead to shortages. At the same time, the arrival of new treatments is accompanied by regulatory constraints, complex price negotiations, and high costs for the community. Ensuring equitable and sustainable access to medicines requires combining solidarity and innovation, rethinking regulation, securing production, and promoting the central role of pharmacists.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 26-30"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Singularité des parcours en oncologie, une vision européenne à l’Esmo 2025","authors":"Jérôme Sicard (Docteur en pharmacie)","doi":"10.1016/j.actpha.2026.02.011","DOIUrl":"10.1016/j.actpha.2026.02.011","url":null,"abstract":"<div><div>Le vécu de chaque parcours de soins en oncologie est unique. De nombreux critères vont l’influencer, notamment l’âge du patient lors de son diagnostic, ses représentations, son isolement social ou géographique. Ils font partie d’un ensemble de facteurs qui vont largement moduler l’adhésion de la personne à son traitement.</div></div><div><div>Each oncology care journey is unique. Many factors influence it, including the patient’s age at diagnosis, their perceptions, and their social or geographical isolation. These are part of a set of factors that will greatly influence the person’s adherence to their treatment.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 43-46"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accès dérogatoires aux médicaments, une exception française","authors":"Carole Ratsimbazafy (Docteure en pharmacie, pharmacienne des hôpitaux) ,&nbsp;Voa Ratsimbazafy (Docteure en pharmacie, pharmacienne des hôpitaux)","doi":"10.1016/j.actpha.2026.02.008","DOIUrl":"10.1016/j.actpha.2026.02.008","url":null,"abstract":"<div><div>En France, un accès particulier aux produits médicamenteux est envisageable à travers les dispositifs dérogatoires à l’autorisation de mise sur le marché, l’accès précoce et l’accès compassionnel. L’objectif est d’accélérer la mise à disposition de médicaments pouvant bénéficier à des patients n’ayant pas de solution thérapeutique.</div></div><div><div>In France, special access to medicinal products is possible through marketing authorization exemptions, early access, and compassionate use programs. The aim is to speed up the availability of medicines that could benefit patients who have no other therapeutic options.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"65 655","pages":"Pages 31-34"},"PeriodicalIF":0.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147570751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}